DK130387A - Transglutaminase inhibitorer - Google Patents
Transglutaminase inhibitorerInfo
- Publication number
- DK130387A DK130387A DK130387A DK130387A DK130387A DK 130387 A DK130387 A DK 130387A DK 130387 A DK130387 A DK 130387A DK 130387 A DK130387 A DK 130387A DK 130387 A DK130387 A DK 130387A
- Authority
- DK
- Denmark
- Prior art keywords
- transglutaminase inhibitors
- transglutaminase
- inhibitors
- dihydroisoxazoles
- acne
- Prior art date
Links
- 108060008539 Transglutaminase Proteins 0.000 title abstract 3
- 102000003601 transglutaminase Human genes 0.000 title abstract 3
- 239000003112 inhibitor Substances 0.000 title abstract 2
- WEQPBCSPRXFQQS-UHFFFAOYSA-N 4,5-dihydro-1,2-oxazole Chemical class C1CC=NO1 WEQPBCSPRXFQQS-UHFFFAOYSA-N 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83974386A | 1986-03-14 | 1986-03-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK130387D0 DK130387D0 (da) | 1987-03-13 |
| DK130387A true DK130387A (da) | 1987-09-15 |
Family
ID=25280527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK130387A DK130387A (da) | 1986-03-14 | 1987-03-13 | Transglutaminase inhibitorer |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0237082B1 (da) |
| JP (1) | JPS62252779A (da) |
| KR (1) | KR900006545B1 (da) |
| AT (1) | ATE63906T1 (da) |
| AU (1) | AU599636B2 (da) |
| DE (1) | DE3770294D1 (da) |
| DK (1) | DK130387A (da) |
| ES (1) | ES2038609T3 (da) |
| GR (1) | GR3002022T3 (da) |
| HU (2) | HU201032B (da) |
| IL (1) | IL81887A0 (da) |
| NZ (1) | NZ219607A (da) |
| ZA (1) | ZA871860B (da) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2738486B2 (ja) * | 1992-11-20 | 1998-04-08 | ファイザー製薬株式会社 | 抗炎症剤としての新規なイソオキサゾリン類 |
| AU691201B2 (en) * | 1993-11-01 | 1998-05-14 | Japat Ltd. | Endothelin receptor antagonists |
| IL118325A0 (en) * | 1995-05-25 | 1996-10-31 | Pont Merck And Pharmaceutical | Integrin receptor antagonists and pharmaceutical compositions containing them |
| US5710159A (en) * | 1996-05-09 | 1998-01-20 | The Dupont Merck Pharmaceutical Company | Integrin receptor antagonists |
| SK56798A3 (en) * | 1995-10-30 | 1998-12-02 | Smithkline Beecham Corp | Protease inhibitors, pharmaceutical composition containing them and their use |
| US6586466B2 (en) | 1995-10-30 | 2003-07-01 | Smithkline Beecham Corporation | Carbohydrazide-protease inhibitors |
| AU7937298A (en) | 1997-07-08 | 1999-02-08 | Ono Pharmaceutical Co. Ltd. | Amino acid derivatives |
| TWI245035B (en) | 1998-06-26 | 2005-12-11 | Ono Pharmaceutical Co | Amino acid derivatives and a pharmaceutical composition comprising the derivatives |
| KR100633349B1 (ko) | 1998-07-14 | 2006-10-16 | 오노 야꾸힝 고교 가부시키가이샤 | 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제 |
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| US6583137B1 (en) | 1999-11-10 | 2003-06-24 | Smithkline Beecham Corporation | Protease inhibitors |
| JP2003513971A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテア−ゼ阻害剤 |
| EP1229914A4 (en) | 1999-11-10 | 2004-06-23 | Smithkline Beecham Corp | PROTEASE INHIBITORS |
| KR20020082896A (ko) | 2000-03-21 | 2002-10-31 | 스미스클라인 비참 코포레이션 | 프로테아제 억제제 |
| DE60336754D1 (de) | 2002-02-14 | 2011-05-26 | Univ R | Enzymbehandlung von nahrungsmitteln für zöliakie-sprue |
| US8143210B2 (en) | 2002-02-14 | 2012-03-27 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for celiac sprue |
| US6902781B2 (en) | 2002-04-08 | 2005-06-07 | Konica Corporation | Ink-jet recording medium, silica particles and silica dispersion |
| US7265093B2 (en) * | 2002-05-14 | 2007-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for Celiac Sprue |
| US7605150B2 (en) | 2002-05-14 | 2009-10-20 | The Board Of Trustees Of The Leland Stanford Junior University | Drug therapy for Celiac Sprue |
| EP1563300B1 (en) | 2002-11-20 | 2012-04-18 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic method for celiac sprue |
| US7579313B2 (en) | 2003-11-18 | 2009-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Transglutaminase inhibitors and methods of use thereof |
| US7628985B2 (en) | 2004-04-26 | 2009-12-08 | The Board Of Regents Of The Leland Stanford Junior University | Therapeutic enzyme formulations and uses thereof in celiac sprue and/or dermatitis herpetoformis |
| GB0515003D0 (en) | 2005-07-21 | 2005-08-31 | Univ Aston | Medical devices and coatings therefor |
| CA2680590C (en) | 2007-03-16 | 2017-10-17 | Jonathan David Gass | Combination enzyme therapy for digestion of dietary gluten |
| AR067329A1 (es) * | 2007-06-13 | 2009-10-07 | Bristol Myers Squibb Co | Analogos dipeptidos como inhibidores del factor de coagulacion |
| CA2706630A1 (en) * | 2007-11-27 | 2009-06-04 | Kenneth Nicholis Dolynchuk | Use of transglutaminase inhibitor in skin treatment |
| US9149465B2 (en) | 2009-05-18 | 2015-10-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| US8927551B2 (en) | 2009-05-18 | 2015-01-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| US8765735B2 (en) | 2009-05-18 | 2014-07-01 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4283403A (en) * | 1976-06-14 | 1981-08-11 | Eli Lilly And Company | Substituted isoxazolines for control of plant phytopathogens |
| WO1981001145A1 (en) * | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
| US4481190A (en) | 1982-12-21 | 1984-11-06 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists |
-
1987
- 1987-03-13 AT AT87103700T patent/ATE63906T1/de not_active IP Right Cessation
- 1987-03-13 NZ NZ219607A patent/NZ219607A/en unknown
- 1987-03-13 ZA ZA871860A patent/ZA871860B/xx unknown
- 1987-03-13 ES ES198787103700T patent/ES2038609T3/es not_active Expired - Lifetime
- 1987-03-13 EP EP87103700A patent/EP0237082B1/en not_active Expired - Lifetime
- 1987-03-13 IL IL81887A patent/IL81887A0/xx not_active IP Right Cessation
- 1987-03-13 KR KR1019870002237A patent/KR900006545B1/ko not_active Expired
- 1987-03-13 HU HU871105A patent/HU201032B/hu not_active IP Right Cessation
- 1987-03-13 HU HU885805A patent/HU199809B/hu not_active IP Right Cessation
- 1987-03-13 AU AU69987/87A patent/AU599636B2/en not_active Ceased
- 1987-03-13 DE DE8787103700T patent/DE3770294D1/de not_active Expired - Lifetime
- 1987-03-13 DK DK130387A patent/DK130387A/da not_active Application Discontinuation
- 1987-03-13 JP JP62059922A patent/JPS62252779A/ja active Pending
-
1991
- 1991-05-30 GR GR90400772T patent/GR3002022T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT44244A (en) | 1988-02-29 |
| IL81887A0 (en) | 1987-10-20 |
| HU199809B (en) | 1990-03-28 |
| EP0237082A2 (en) | 1987-09-16 |
| AU6998787A (en) | 1987-09-17 |
| KR900006545B1 (ko) | 1990-09-13 |
| KR870008863A (ko) | 1987-10-21 |
| JPS62252779A (ja) | 1987-11-04 |
| ATE63906T1 (de) | 1991-06-15 |
| DK130387D0 (da) | 1987-03-13 |
| EP0237082B1 (en) | 1991-05-29 |
| HU201032B (en) | 1990-09-28 |
| GR3002022T3 (en) | 1992-12-30 |
| ZA871860B (en) | 1988-10-26 |
| DE3770294D1 (de) | 1991-07-04 |
| ES2038609T3 (es) | 1993-08-01 |
| EP0237082A3 (en) | 1988-09-14 |
| NZ219607A (en) | 1990-11-27 |
| AU599636B2 (en) | 1990-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK130387D0 (da) | Transglutaminase inhibitorer | |
| ATE233558T1 (de) | Verwendung von strontiumsälze zur behandlung von arthrose | |
| NO890408D0 (no) | 3-indolpyrodruesyre-derivater og deres farmasoeytiske anvendelse. | |
| NO872589D0 (no) | Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon. | |
| FI895213A0 (fi) | Foereningar avsedda foer vaord av alzheimers sjukdom. | |
| EP0735870A4 (en) | Use of pla 2? inhibitors as treatment for alzheimer's disease | |
| DE3780618D1 (de) | Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses. | |
| KR920700634A (ko) | 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물 | |
| DE68907423D1 (de) | Behandlung der akne. | |
| FI820115L (fi) | Tetrahydronaftalen- och indanfoereningar | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| FI864570A0 (fi) | Terapeutiskt anvaendbar foerening. | |
| ATE95694T1 (de) | Verwendung von bezafibrat zur behandlung von diabetes. | |
| DE3856329D1 (de) | Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie | |
| DE3680507D1 (de) | Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie. | |
| DE68911776D1 (de) | Konjugierte Oxybutenolide zur Behandlung von Ulcera. | |
| DE3680881D1 (de) | Behandlung von hologrammen. | |
| DK146890D0 (da) | Mercapto-acylaminosyre-antihypertensiva | |
| FI844645A0 (fi) | 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar. | |
| DE3684825D1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
| FI854034A7 (fi) | Menetelmä biolietteen lämpökäsittelemiseksi. | |
| DE3683330D1 (de) | Verwendung von imidazolinylaminoisoindolen und verwandten verbindungen zur behandlung von hyperglykaemie. | |
| DE3586321D1 (de) | Verwendung von 1,4-dihydropyridinderivaten. | |
| ATE91231T1 (de) | Behandlung der akne. | |
| DE3890823T1 (de) | Anordnung von druckduesen zur behandlung von warenbahnen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired | ||
| AHB | Application shelved due to non-payment |